The latest closing stock price for Theravance Biopharma as of November 21, 2024 is 9.61.
An investor who bought $1,000 worth of Theravance Biopharma stock at the IPO in 2014 would have $-581 today, roughly -1 times their original investment - a -7.61% compound annual growth rate over 11 years.
The all-time high Theravance Biopharma stock closing price was 42.56 on June 22, 2017.
The Theravance Biopharma 52-week high stock price is 11.71, which is 21.9% above the current share price.
The Theravance Biopharma 52-week low stock price is 7.44, which is 22.6% below the current share price.
The average Theravance Biopharma stock price for the last 52 weeks is 9.12.
An investor who bought $1,000 worth of Theravance Biopharma stock at the IPO in 2014 would have $-581 today, roughly -1 times their original investment - a -7.61% compound annual growth rate over 11 years.
The all-time high Theravance Biopharma stock closing price was 42.56 on June 22, 2017.
The Theravance Biopharma 52-week high stock price is 11.71, which is 21.9% above the current share price.
The Theravance Biopharma 52-week low stock price is 7.44, which is 22.6% below the current share price.
The average Theravance Biopharma stock price for the last 52 weeks is 9.12.